2005
DOI: 10.1590/s0074-02762005000900015
|View full text |Cite
|
Sign up to set email alerts
|

CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 39 publications
1
17
0
Order By: Relevance
“…The major challenge in designing an efficacious treatment for T. cruzi-elicited myocarditis is that any strategy must be able to decrease the intense inflammation, which produces severe tissue damage, without hampering the host's ability to control the parasite load (Marino et al 2005). The currently available therapeutic options for CD are limited.…”
Section: Discussionmentioning
confidence: 99%
“…The major challenge in designing an efficacious treatment for T. cruzi-elicited myocarditis is that any strategy must be able to decrease the intense inflammation, which produces severe tissue damage, without hampering the host's ability to control the parasite load (Marino et al 2005). The currently available therapeutic options for CD are limited.…”
Section: Discussionmentioning
confidence: 99%
“…Other inflammatory mediators and chemokines such as IL-18 and CCR7 ligands, upmation in response to chemokines such as CCL2, CCL3, CCL4, CCL5, CXCL10 and CCR5 [41] . The blockade of one, CCR5, by Met-RANTES significantly decreased the intensity of cardiac inflammatory infiltrate, suggesting that lymphocyte migration to the myocardium during acute infection is dependent on CCR5 ligands [42,43] . IFN-γ-inducible adhesion molecules, such as fibronectin and VCAM-1, can also be detected at high levels in cardiac tissue from T. cruzi-infected mice [44] .…”
Section: Ifn-γ Acts As An Immunological Mediator Inducing Protection mentioning
confidence: 97%
“…A growing concern is our understanding of these coinfections, which demand further investigations in regions of the world where this disease is both endemic and not endemic (410). In this respect, a comprehension of the pathogeneses of coinfections involved is crucial for the delivery of new therapeutic strategies, and chemokine receptors may become important therapeutic targets for immunosuppressed patients (263).…”
Section: Immunosuppressionmentioning
confidence: 99%